Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the biggest names in the biotechnology sector. The company has already-approved assets (of which there are six so far) and pipeline-based development drugs (of which there are around 15 right now) designed to target a whole host of different indications, from eye disease to heart disease, to pain, cancer, infectious diseases and rare diseases.
Editor’s Note: Chris Johnson has worked in finance for more than 20 years, holding the titles Director of Research and Director of Quantitative Analysis (“quants” are kind of like the rocket scientists of investing) at a well-known equity and options research firm. You’re going to be hearing a lot more from him soon, but he wanted us to get in touch right away with this....More>>>
Theres no clear consensus on how Apple Inc. (NSDQ:AAPL)will perform in China, as retail channel checks suggestdemand is robust in China.
However,the Chinese retail commentary wasnt very supportive in the month of October, and Im guessing that was attributed to Apples cautious stance on channel inventory, as Apple reduced channel inventory by a couple of weeks, which reduced production at....More>>>
Gold edged lower on Monday, retreating further from last week's 3 - 1/2 - month high as the U.S. dollar regained some ground against the buoyant euro and traders bet on further U.S. interest rate hikes after Friday's payrolls data. The dollar, which
On Dec. 15, 2017, the share of Omeros Corporation (NASDAQ:OMER) - a bioscience focusing on the innovation and commercialization of drugs to treat complement-mediated diseases, inflammation, and central nervous system disorders - appreciated $0.47 to trade at $19.68 for 3.52% profits (a
Beating Alzheimers is going to be a team sport. We now have our new quarterback. Referencing billionaire Microsoft co-founder Bill Gates announcement today to join the fight to cure Alzheimers, George Vradenburg, chairman, president and co-founder of UsAgainstAlzheimers - a movement bent on stop
U.S. equities rebounded from the steep losses suffered on Wednesday as investors looked ahead to a batch of earnings from big stocks after the close. Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT) and Alphabet Inc (NASDAQ:GOOG, NASDAQ:GOOGL) all reported top- and b
U.S. equities moved lower again on Wednesday, pushing the major averages down to levels not seen since the middle of October. In the end, the Dow Jones Industrial Average lost 0.6%, the S&P 500 lost 0.6%, the Nasdaq Composite lost 0.5% and the Russell 2000 lost 0.5%. It was the second-straig